**Peter Attia**, a longevity expert with ties to the late **Jeffrey Epstein**, has parted ways with **David Protein**, a company he was associated with. This development comes as **Attia**’s own startup, **Biograph**, a longevity medical testing company he co-founded, has declined to comment on the matter. **Biograph** emerged from stealth mode just a year ago, marking a significant milestone in the longevity medical testing space.
Details surrounding **Attia**’s departure from **David Protein** are scarce, with **Biograph** maintaining silence on the issue. **Attia**’s involvement with **David Protein** was notable, given his expertise in longevity and health optimization. The split raises questions about the future direction of both **David Protein** and **Biograph**. **Biograph**’s focus on longevity medical testing has been an area of interest, especially given the growing attention to health and wellness technologies.
The impact of **Attia**’s departure from **David Protein** and the silence from **Biograph** may have significant implications for the longevity and health tech industries. As companies like **Nvidia**, **Ring**, and **OpenAI** continue to push boundaries in their respective fields, the health and wellness sector is also experiencing rapid growth and innovation. **Attia**’s involvement in the space, and the developments surrounding his departure, will likely be closely watched by industry observers and investors alike.
Leave a Reply